一次性内视镜市场机会、成长动力、产业趋势分析及2025-2034年预测

2024 年全球一次性内视镜市场规模达 19 亿美元，预计到 2034 年将以 16.4% 的复合年增长率成长，达到 85 亿美元。这一显着增长主要得益于人们对微创手术的日益青睐，以及癌症和胃肠道疾病等慢性疾病的日益普及。发炎性肠道疾病、消化性溃疡、大肠直肠癌和食道併发症等疾病的发生率稳定上升，这主要归因于不良的饮食习惯、久坐的生活方式和人口老化，这持续推动了对早期诊断工具的需求。由于这些疾病通常需要频繁检查，一次性内视镜已成为更安全的选择，可以降低医院内感染的风险以及可重复使用内视镜可能发生的交叉污染。

专为一次性使用的内视镜设计，无论是柔性内视镜或刚性内视镜，均具备诊断与治疗功能。其主要优点之一是无需复杂的灭菌过程，非常适合在床边或急救环境中使用。整合CMOS感测器技术的经济高效的设计提高了成像清晰度和手术过程中的即时可视性，推动了其在各种医疗环境中，尤其是在资源有限的环境中的进一步应用。

预计支气管镜市场将强劲扩张，复合年增长率达17%，到2034年将达31亿美元。一次性支气管镜日益受到青睐，是因为它们能够最大限度地降低重症监护室（ICU）等高风险环境中的感染风险。这些设备因其即用型功能而备受青睐，尤其是在重症监护和创伤治疗场景中，这些场景需要快速干预，而传统内视镜的重复处理又不切实际。

2024年，医院占了最大的市场份额，占63.9%。由于手术量大且基础设施完善，医院逐渐转向一次性内视镜解决方案，以提高安全性和营运效率。传统的可重复使用内视镜，尤其是在外科手术科室，有较高的感染传播风险。相较之下，一次性内视镜的感染风险较低，因此在医院内感染（HAI）对病患健康和机构成本构成重大风险的关键科室中，一次性内视镜成为首选。

美国一次性内视镜市场在2024年达到8.959亿美元，预计到2034年将以15.3%的复合年增长率成长。美国领先的地位得益于其完善的医疗保健体系、较高的手术量以及对创新技术的早期应用。对感染控制措施的日益重视进一步刺激了对一次性解决方案的需求。优惠的报销结构、FDA的监管支持以及国内企业的大量研发投入，也为快速的产品开发和市场扩张创造了有利环境。

引领一次性内视镜产业的主要参与者包括奥林巴斯、HugeMed、波士顿科学、RICHARD WOLF、Flexicare、Ambu、Karl Storz、CooperSurgical、Parburch MEDICAL 和 Hoya Corporation。该市场的领先公司正专注于新产品发布、策略合作和技术创新，以加强其影响力。许多公司正在投资先进的影像技术和人体工学，以提高可用性和程序效率。此外，公司也正在进行併购，以扩大产品组合併进入尚未开发的区域市场。一些参与者强调可扩展的生产能力和经济实惠的设计，以满足新兴经济体日益增长的需求。同时，与医院和临床研究机构的合作有助于验证产品性能并推动其在医疗环境中的更广泛应用。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 胃肠道疾病、癌症和其他慢性疾病发生率上升
    • 微创手术的需求不断增加
    • 一次内视镜的技术进步
    • 更加重视污染和感染控制
  • 产业陷阱与挑战
    • 缺乏熟练的医师和内视镜医师
  • 市场机会
    • 监理推动感染控制
• 成长潜力分析
• 监管格局
  • 北美洲
  • 欧洲
  • 排
• 技术和创新格局
  • 当前的技术趋势
  • 新兴技术
• 定价分析
• 报销场景
• 差距分析
• 波特的分析
• 管道分析
• PESTEL分析
• 差距分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
  • 按地区
    • 北美洲
    • 欧洲
    • 排
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係和合作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：依产品类型，2021 - 2034 年

• 主要趋势
• 支气管镜
• 膀胱镜
• 十二指肠镜
• 子宫腔镜
• 喉镜
• 输尿管镜
• 其他产品类型

第六章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用途

第七章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 排

第八章：公司简介

• Ambu
• Boston Scientific
• CooperSurgical
• Flexicare
• Hoya Corporation
• HugeMed
• Karl Storz
• OLYMPUS
• Parburch MEDICAL
• RICHARD WOLF

The Global Disposable Endoscopes Market was valued at USD 1.9 billion in 2024 and is estimated to grow at a CAGR of 16.4% to reach USD 8.5 billion by 2034. This notable growth is largely driven by the increasing preference for minimally invasive procedures and the growing prevalence of chronic diseases such as cancer and gastrointestinal disorders. A steady rise in conditions like inflammatory bowel disease, peptic ulcers, colorectal cancer, and esophageal complications-largely attributed to poor dietary habits, sedentary lifestyles, and aging populations-continues to boost the need for early diagnostic tools. As these conditions often demand frequent examinations, disposable endoscopes have emerged as a safer option, reducing the risk of hospital-acquired infections and cross-contamination that may occur with reusable scopes.

Designed for single-use, disposable endoscopes-whether flexible or rigid-offer both diagnostic and therapeutic capabilities. One of their major advantages is that they eliminate the need for complex sterilization processes, making them ideal for use in point-of-care or emergency settings. The introduction of cost-effective designs integrated with CMOS sensor technology has improved imaging clarity and real-time visibility during procedures, driving further adoption in various healthcare environments, especially in resource-limited settings.

The bronchoscopes segment is forecasted to witness strong expansion, growing at a CAGR of 17% to reach USD 3.1 billion by 2034. The rising inclination toward single-use bronchoscopes stems from their ability to minimize infection risks in high-stakes environments like ICUs. These devices are now preferred for their ready-to-use functionality, especially in critical care and trauma scenarios where rapid intervention is necessary and time-consuming reprocessing of traditional scopes is impractical.

In 2024, hospitals accounted for the largest share of the market, generating 63.9%. With a high procedural load and established infrastructure, hospitals are increasingly transitioning to disposable endoscopic solutions to enhance safety and operational efficiency. Traditional reusable scopes, especially in surgical units, present a greater risk of infection transmission. In contrast, disposable scopes offer a lower infection profile, making them a preferred choice in critical departments where HAIs pose a significant risk to patient health and institutional costs.

United States Disposable Endoscopes Market generated USD 895.9 million in 2024 and is set to grow at a CAGR of 15.3% through 2034. The country's leading position is supported by a well-established healthcare system, high surgical volumes, and early adoption of innovative technologies. Growing emphasis on infection control practices has further fueled demand for disposable solutions. Favorable reimbursement structures, regulatory support from the FDA, and substantial R&D investments from domestic companies have also created an environment conducive to rapid product development and market expansion.

Key players leading the Disposable Endoscopes Industry include Olympus, HugeMed, Boston Scientific, RICHARD WOLF, Flexicare, Ambu, Karl Storz, CooperSurgical, Parburch MEDICAL, and Hoya Corporation. Leading companies in this market are focusing on new product launches, strategic collaborations, and technological innovation to strengthen their presence. Many are investing in advanced imaging technologies and ergonomics to enhance usability and procedural efficiency. Mergers and acquisitions are also being pursued to expand product portfolios and gain access to untapped regional markets. Some players are emphasizing scalable production capabilities and affordable designs to cater to growing demand from emerging economies. At the same time, partnerships with hospitals and clinical research institutions are helping to validate product performance and drive broader adoption across healthcare settings.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product type
  • 2.2.3 End use

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidences of gastrointestinal disorders, cancer, and other chronic conditions
    • 3.2.1.2 Increasing demand for minimally invasive procedures
    • 3.2.1.3 Technological advancements in disposable endoscopes
    • 3.2.1.4 Increased focus on contamination and infection control
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled physicians and endoscopists
  • 3.2.3 Market opportunities
    • 3.2.3.1 Regulatory push for infection control
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 RoW
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Pricing analysis
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 Pipeline analysis
• 3.11 PESTEL analysis
• 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 By region
    • 4.3.1.1 North America
    • 4.3.1.2 Europe
    • 4.3.1.3 RoW
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn, Units)

• 5.1 Key trends
• 5.2 Bronchoscopes
• 5.3 Cystoscopes
• 5.4 Duodenoscopes
• 5.5 Hysteroscopes
• 5.6 Laryngoscopes
• 5.7 Ureteroscopes
• 5.8 Other product types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Ambulatory surgical centers
• 6.4 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn, Units)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 RoW

Chapter 8 Company Profiles

• 8.1 Ambu
• 8.2 Boston Scientific
• 8.3 CooperSurgical
• 8.4 Flexicare
• 8.5 Hoya Corporation
• 8.6 HugeMed
• 8.7 Karl Storz
• 8.8 OLYMPUS
• 8.9 Parburch MEDICAL
• 8.10 RICHARD WOLF